BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (XFOR) (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results